Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
186 hedge funds and large institutions have $2.84B invested in Axonics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 78 increasing their positions, 55 reducing their positions, and 22 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 55
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
10% more capital invested
Capital invested by funds: $2.59B → $2.84B (+$258M)
3% more funds holding
Funds holding: 180 → 186 (+6)
38% less call options, than puts
Call options by funds: $4.21M | Put options by funds: $6.82M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$18.4M |
| 2 |
Jennison Associates
New York
|
+$18.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$17.7M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$17.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.2M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21.8M |
| 3 |
AC
Armistice Capital
New York
|
-$21.7M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$19.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$16.3M |
AXNX Hedge Fund Activity: Q1 2022 in Review
186 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2022, worth a combined $2.84B — up 10% from $2.59B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new AXNX positions and 22 closed out — a net gain of 8 holders — while 78 added to existing stakes and 55 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $18.4M. The largest seller was Fidelity Investments, cutting an estimated $28.2M.
- 186 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2022, up from 180 in Q4 2021.
- Funds reported $2.84B of Axonics, Inc. Common Stock stock for Q1 2022, up 10% quarter-over-quarter.
- 30 funds opened new Axonics, Inc. Common Stock positions in Q1 2022 and 22 closed out, a net change of +8 holders.
- The largest Axonics, Inc. Common Stock buyer in Q1 2022 was Perceptive Advisors, an estimated $18.4M added.
- The largest Axonics, Inc. Common Stock seller in Q1 2022 was Fidelity Investments, an estimated $28.2M sold.
Based on aggregated 13F filings for Q1 2022.